Matthew DurhamOmnidynamic Marketing
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Amy GilesIncreasing Engagement
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Paul TheisenPatient Acquisition
Stacey GandlerBrand Nourishment
Joey CohenMedication Adherence
Pat PurcellMeeting Engagement
ZEJULA is the #1 PARP inhibitor for women with ovarian cancer in the U.S.2017 ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email